HIV-child

  • 文章类型: Case Reports
    背景:由于缺乏在儿科环境中使用新药的经验,因此在儿童中管理多药耐药(MDR)HIV感染尤其具有挑战性。在一线治疗失败后,具有优化的抗逆转录病毒背景疗法的二线白蛋白(ABT)被批准用于成人和青少年。本文描述了基于ABT的双重活性抗逆转录病毒治疗方案在患有MDRHIV毒株的儿童中的治疗结果和不良反应。
    方法:一名13岁的中国女性患者感染了MDRHIV病毒株,在使用基于ABT的抗逆转录病毒方案治疗12个月后,病毒载量降低(从4.48log10降低至1.73log10),CD4+T细胞增加(从15至308细胞/μl)。患儿未出现与药物相关的不良反应。
    结论:本文报道的病例可能表明,基于ABT的抗逆转录病毒疗法可能对患有MDRHIV的儿童有益,并且没有相关毒性。专门管理艾滋病毒的传染病学家应该准备好管理越来越多的患有MDR艾滋病毒的儿童。ABT可能是儿童MDRHIV感染的新治疗选择。
    Managing multidrug-resistant (MDR) HIV infections in children is particularly challenging due to the lack of experience with new drugs in the pediatric setting. Second-line albuvirtide (ABT) with an optimized antiretroviral background therapy was approved for adults and adolescents after first-line treatment failure. This paper describes the treatment outcomes and adverse effects of an ABT-based dual-active antiretroviral treatment regimen in a child with MDR HIV strains.
    A 13 year-old Chinese female patient infected with MDR HIV strains showed a decrease in viral load (from 4.48 log10 to 1.73 log10) and an increase in CD4 + T cells (from 15 to 308 cells/µl) after 12 months of treatment with an ABT-based antiretroviral regimen. The child showed no relevant drug-related adverse reactions.
    The case reported here could suggest that an ABT-based antiretroviral therapy might be beneficial and without relevant toxicity in children with MDR HIV. Infectiologists specializing in managing HIV should be prepared to manage an increasing number of children with MDR HIV. ABT might be a new treatment option for MDR HIV infection in children.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    马尔尼菲塔拉酵母(马尔尼菲青霉菌,T.marneffei)在成人获得性免疫缺陷综合征患者中经常有报道。尽管如此,感染艾滋病毒的儿童合并马尔尼菲感染的病例非常罕见。本报告描述了一名来自中国的女孩感染艾滋病毒的情况。其特殊的临床表现和实验室诊断结果可为临床医生诊断和治疗马尔尼菲氏杆菌相关罕见病提供依据。
    我们报告了一例7岁的中国女性患者出现发烧,腹痛,多发性淋巴结病,肝脾肿大,左下肢瘀斑,还有血淋淋的凳子.患者接受了抗炎治疗;然而,她的症状没有改善。因此,她被诊断出患有T.marneffei和HIV感染;还证实她的母亲在怀孕期间没有接受HIV阻断治疗。然而,孩子的家人拒绝了所有的治疗,之后孩子出院了。患者几天后死亡。
    这个病例提示患有艾滋病的儿童发烧,淋巴结病和凝血功能障碍,应该怀疑青霉病。临床医生应通过实验室和影像学结果早期诊断疾病,这可以帮助降低死亡率,延长患儿的生存时间,提高患儿的生活质量。
    Talaromyces Marneffei (Penicillium marneffei, T.marneffei) has been frequently reported in patients with adult acquired immunodeficiency syndrome. Still, cases of children with HIV combined with T.marneffei infection are very rare. This report describes the case of a HIV-child who is a girl from China. Her special clinical manifestations and laboratory diagnosis results can provide clinicians with the basis for diagnosis and treatment of T.marneffei related rare diseases.
    We reported a single case of 7-year-old Chinese female patient who presented with fever, abdominal pain, multiple lymphadenopathy, hepatosplenomegaly, left lower extremity ecchymosis, and bloody stool. The patient received anti-inflammatory therapy; however, her symptoms did not improve. Consequently, she was diagnosed with T.marneffei and HIV infection; it was also confirmed that her mother did not undergo HIV blocking therapy during pregnancy. Yet, the child\'s family refused all treatment, after which the child was discharged from the hospital. The patient died a few days later.
    This case suggested that children with AIDS suffering from fever, lymphadenopathy and coagulation dysfunction, penicilliosis should be suspected. Clinicians should diagnose the disease early through laboratory and imaging results, which can help reduce the mortality, prolong the survival time and improve the quality of life of children.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号